DE3880874T2 - Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. - Google Patents

Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.

Info

Publication number
DE3880874T2
DE3880874T2 DE88400693T DE3880874T DE3880874T2 DE 3880874 T2 DE3880874 T2 DE 3880874T2 DE 88400693 T DE88400693 T DE 88400693T DE 3880874 T DE3880874 T DE 3880874T DE 3880874 T2 DE3880874 T2 DE 3880874T2
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
production process
compositions containing
morpholine derivatives
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88400693T
Other languages
English (en)
Other versions
DE3880874D1 (de
Inventor
Gilbert Regnier
Claude Guillonneau
Jean Lepagnol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE3880874D1 publication Critical patent/DE3880874D1/de
Application granted granted Critical
Publication of DE3880874T2 publication Critical patent/DE3880874T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Control For Baths (AREA)
  • Earth Drilling (AREA)
DE88400693T 1987-03-24 1988-03-23 Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. Expired - Fee Related DE3880874T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8704047A FR2612926B1 (fr) 1987-03-24 1987-03-24 Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
DE3880874D1 DE3880874D1 (de) 1993-06-17
DE3880874T2 true DE3880874T2 (de) 1993-12-23

Family

ID=9349348

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88400693T Expired - Fee Related DE3880874T2 (de) 1987-03-24 1988-03-23 Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.

Country Status (17)

Country Link
US (1) US4782054A (de)
EP (1) EP0286495B1 (de)
JP (1) JPH0657709B2 (de)
AT (1) ATE89281T1 (de)
AU (1) AU600209B2 (de)
CA (1) CA1313870C (de)
DE (1) DE3880874T2 (de)
DK (1) DK171580B1 (de)
ES (1) ES2006390A6 (de)
FR (1) FR2612926B1 (de)
GR (1) GR1000241B (de)
HK (1) HK57297A (de)
IE (1) IE61882B1 (de)
NZ (1) NZ223984A (de)
OA (1) OA08822A (de)
PT (1) PT87061B (de)
ZA (1) ZA882107B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653999A1 (fr) * 1989-11-06 1991-05-10 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5637699A (en) * 1992-06-29 1997-06-10 Merck & Co., Inc. Process for preparing morpholine tachykinin receptor antagonists
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
AU2005238296A1 (en) * 2004-04-30 2005-11-10 Warner-Lambert Company Llc Substituted morpholine compounds for the treatment of central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138405A (en) * 1966-12-28 1969-01-01 Ici Ltd Morpholine derivatives
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la

Also Published As

Publication number Publication date
CA1313870C (fr) 1993-02-23
ZA882107B (en) 1989-06-28
NZ223984A (en) 1990-05-28
DE3880874D1 (de) 1993-06-17
PT87061B (pt) 1992-07-31
FR2612926B1 (fr) 1989-06-09
JPS63255279A (ja) 1988-10-21
PT87061A (pt) 1988-04-01
DK150088D0 (da) 1988-03-18
IE61882B1 (en) 1994-11-30
AU600209B2 (en) 1990-08-02
AU1352088A (en) 1988-09-22
HK57297A (en) 1997-05-09
EP0286495B1 (de) 1993-05-12
GR880100179A (en) 1989-01-31
ATE89281T1 (de) 1993-05-15
US4782054A (en) 1988-11-01
IE880851L (en) 1988-09-24
ES2006390A6 (es) 1989-04-16
EP0286495A1 (de) 1988-10-12
DK171580B1 (da) 1997-02-03
OA08822A (fr) 1989-03-31
JPH0657709B2 (ja) 1994-08-03
FR2612926A1 (fr) 1988-09-30
GR1000241B (el) 1992-05-12
DK150088A (da) 1988-09-25

Similar Documents

Publication Publication Date Title
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
DE3880874T2 (de) Morpholin-Derivate, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE9472T1 (de) Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ATE3429T1 (de) Paromomycin-derivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammenzetzung.
AU610173B2 (en) New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
FR2703048B1 (fr) Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
HUT48464A (en) Process for producing pharmaceutical composition for treating hypertonia and cardiac failure
GR860679B (en) Novel 3-pyridylmethylnaphthyl derivatives method for their preparation and their use as medicine
ATE104976T1 (de) Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
HUT46909A (en) Process for production of substituated quinoxanileimidasoline-2,4-dions and medical preparatives containing such compositions
ATE119149T1 (de) Pyrrolidonderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ZA807789B (en) Piperidine derivatives,their preparation,and pharmaceutical formulations containing these compounds
IL85229A0 (en) Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof
DE3680893D1 (de) Pyrimido(5,4-b)(1,4)oxazinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie zwischenprodukte darstellende pyrimido(5,4-b)(1,4)oxazinderivate.
DE59208954D1 (de) Verfahren zur enzymatischen Herstellung isomerenreiner Isosorbid-2- und 5-monoester sowie deren Überführung in Isosorbid-2- und 5-nitrat
GR80155B (en) Crystalline salts of l or (s) -3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
ZA948515B (en) Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee